Phase I Trial Combining Radiopharmaceutical Therapy (RPT) with Total Marrow and Lymphoid Irradiation (TMLI) in Relapsed or Refractory (R/R) AML
International Journal of Radiation Oncology*Biology*Physics · 2026-05 · 125 (1) · e2
DOI: 10.1016/j.ijrobp.2026.02.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-05. Verfasst von J.Y.C. Wong und 19 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wong, J., Malki, M. A., Yang, D., Adhikarla, V., Sahebi, F., Salhotra, A., Yamauchi, D., Dandapani, S., Song, J., Han, C., Liu, A., Yazaki, P., Shively, J., Wu, A., Hui, S., Smith, E., Marcucci, G., Forman, S., Nakamura, R., & Stein, A. (2026). Phase I Trial Combining Radiopharmaceutical Therapy (RPT) with Total Marrow and Lymphoid Irradiation (TMLI) in Relapsed or Refractory (R/R) AML. International Journal of Radiation Oncology*Biology*Physics, 125(1), e2. https://doi.org/10.1016/j.ijrobp.2026.02.004
Vancouver
Wong J, Malki MA, Yang D, Adhikarla V, Sahebi F, Salhotra A, et al. Phase I Trial Combining Radiopharmaceutical Therapy (RPT) with Total Marrow and Lymphoid Irradiation (TMLI) in Relapsed or Refractory (R/R) AML. International Journal of Radiation Oncology*Biology*Physics. 2026;125(1):e2. doi:10.1016/j.ijrobp.2026.02.004
BibTeX
@article{Wong2026,
author = {Wong, J.Y.C. and Malki, M. Al and Yang, D. and Adhikarla, V. and Sahebi, F. and Salhotra, A. and Yamauchi, D.M. and Dandapani, S.V. and Song, J. and Han, C. and Liu, A. and Yazaki, P. and Shively, J.E. and Wu, A. and Hui, S.K. and Smith, E. and Marcucci, G. and Forman, S.J. and Nakamura, R. and Stein, A.},
title = {Phase I Trial Combining Radiopharmaceutical Therapy (RPT) with Total Marrow and Lymphoid Irradiation (TMLI) in Relapsed or Refractory (R/R) AML},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {125},
number = {1},
pages = {e2},
doi = {10.1016/j.ijrobp.2026.02.004}
}
EUVIMED